<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="116116">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02068768</url>
  </required_header>
  <id_info>
    <org_study_id>AveL100</org_study_id>
    <nct_id>NCT02068768</nct_id>
  </id_info>
  <brief_title>Multicenter Study of the Avenue L Interbody Spinal Fusion System Using VerteBRIDGE Plating and Posterior Fixation</brief_title>
  <official_title>A Prospective, Multicenter, Open Label Clinical Study of the Safety andEfficacy of the Avenue L Interbody Spinal Fusion System Using the VerteBRIDGE Plating System and Supplemental Posterior Fixation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LDR Spine USA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LDR Spine USA</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this prospective clinical study is to examine the short-term safety and
      efficacy of the Avenue®- L interbody Spinal Fusion System with VerteBRIDGE®  plating to
      treat one and two level degenerative disc disease between L2 and S1 with a focus on fusion
      rate.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Time to Improvement in Oswestry Disability Index (ODI) Score</measure>
    <time_frame>preop, 3 mo, 6 mo, 12 mo post op</time_frame>
    <safety_issue>No</safety_issue>
    <description>subject completed questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to Fusion</measure>
    <time_frame>3 mo, 6 mo, 12 mo</time_frame>
    <safety_issue>No</safety_issue>
    <description>Fusion will be assessed by the physician using imaging methods</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time course of Improvement in Quality of Life</measure>
    <time_frame>pre op, 3 mo, 6 mo, 12 mo</time_frame>
    <safety_issue>No</safety_issue>
    <description>subject questionnaire (SF-12) administered at each time point</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage and time course of Improvement in back and leg pain</measure>
    <time_frame>preop, 3 mo, 6 mo, 12 mo</time_frame>
    <safety_issue>No</safety_issue>
    <description>Using a 10 cm line, subject will draw a vertical line indicating the amount of pain subject is experiencing at the time of survey. One  assessment each for right leg, left leg, back pain.  Commonly called the VAS pain scale.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Degenerative Disc Disease</condition>
  <arm_group>
    <arm_group_label>Operated Subjects</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be drawn from the patient populations of the physicians participating in the
        study.  The principal investigators include community physicians in private practice as
        well as physicians affiliated with academic institutions.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must be candidates for on-label use of the Avenue L device (have
             degenerative disc disease, use only at one or two contiguous levels, posterior
             fixation must be used, autograft must be used in the interbody cage)

          -  Subject must be skeletally mature at the time of surgery, i.e. the subject must be at
             least 21 years of age at the time of surgery

          -  Subject should have had a minimum of 6 months of non-operative treatment prior to
             surgery

          -  The placement of the Avenue L device must be a primary surgery

          -  Subject must be willing to sign the consent form and be able to return for all follow
             up visits.

        Exclusion Criteria:

          -  Subject must not have had prior surgery at the operative level(s)

          -  Subject is known to have substance or alcohol addictions

          -  Subject has lateral curvature of the spine (scoliosis, all types)

          -  Subject is a prisoner

          -  Subject is pregnant

          -  Subject has an active infection or sepsis at the time of surgery

          -  Subject has any neuromuscular disorder that would preclude accurate neurologic
             evaluations
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexios Apazidis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Long Island Orthopaedic and Spine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jane M Jacob, PhD</last_name>
    <phone>512-344-3371</phone>
    <email>Jane.Jacob@ldrspine.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Neuro Medical Care Associates</name>
      <address>
        <city>Johnson City</city>
        <state>New York</state>
        <zip>13790</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khalid Sethi, MD</last_name>
      <email>krooney@rcresearchinc.com</email>
    </contact>
    <investigator>
      <last_name>Tuan Bui, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simon Salerno, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>April 1, 2014</lastchanged_date>
  <firstreceived_date>February 19, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fusion</keyword>
  <keyword>lateral interbody fusion system</keyword>
  <keyword>lumbar spine</keyword>
  <keyword>degenerative disc disease</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Spinal Diseases</mesh_term>
    <mesh_term>Intervertebral Disk Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
